Republic Republic Republic
  • Log in
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Republic Venture Opportunities for accredited investors
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Log in Sign up

Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US
  • Log in
  • Sign up
All investors
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Accredited only
Republic Venture Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Spotlight deal
Hamilton Lane Private Infrastructure Fund
Hamilton Lane Private Infrastructure Fund
Get unique access to the full spectrum of private markets with Hamilton Lane
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets
Sharedrops Gift equity as a reward
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services

RMR Laboratories isn't accepting new investments

RMR Laboratories’ deadline was January 1, 2018

Follow the company to stay updated on their progress, including future investment opportunities


Explore new investment opportunities:
View companies raising now
Campaign ended
Logo of RMR Laboratories

RMR Laboratories

Injection-like delivery of cannabis through your skin with a cream
Cannabis Products Veteran Founders B2C Wellness Pharmaceuticals & Medicine
Facebook Telegram Twitter LinkedIn
Featured image of RMR Laboratories
$784,329
Raised
951
Investors
Successfully funded and closed on January 1, 2018.
Invest in RMR Laboratories

Open for investment

Investors in RMR Laboratories also invested in these companies. View more
Logo of Eli Roth's The Horror Section

Eli Roth's The...

A brand-new independent studio from an iconic horror...

Republic Funding Portal · Reg CF
Loading...
Pitch Updates 2 Reviews 320
Invest Invest in RMR Laboratories
Facebook Telegram Twitter LinkedIn
Closed on January 1, 2018. Information may not be up-to-date. Campaign closed on January 1, 2018. Information displayed may not be up-to-date.

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by RMR Laboratories, Inc. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
RMR Laboratories Crowd SAFE RmR Laboratories (renamed as G&G) - Certification of Dissolution .pdf RMR Final Form C.pdf
Loading

Hear from some of the 951 investors in RMR Laboratories


Show more

Deal Highlights

  • Game-changing cannabis delivery technology; 40 US and worldwide patents in process
  • Injection-like speed and efficacy through a topical; proven clinical results
  • Current sales pipeline of $2.2M
  • Secured exclusive deal with largest, most profitable company in cannabis —Advanced Nutrients, Inc — as production and distribution partner
  • Proven effective with professional athletes 
  • Team has over 60 years experience in healthcare and life sciences and 20 years in cannabis
  • Market size $25B by 2022


The problem: 

Until now, there were only two ways to get cannabis into the body — smoke it or eat it. Both options have negative side effects, aren’t convenient, and are inconsistent.

Solution: 

We developed the first and only line of cannabis topicals using a pharmaceutical technology that can deliver cannabis through the skin

First application:

Our first product line targets chronic pain and sports injuries using CBD, which is non-psychoactive.

1 in 3 people in the United States suffer from chronic pain.

We decided to start with these applications because we saw an overwhelming need to develop a natural, effective alternative to pain killers with negative side effects, like opioids. 


We’ve tested our products with elite athletes, coaches, and people who have had chronic pain for decades. 

Here’s is a sample of what they’ve had to say:

  • “I’ve had knee pain every year that I was in the NBA – 16 years – but after using your CBD lotion, I don’t even need to ice my knee or take any painkillers anymore. I’ve given some to my [retired NBA] friends and they’re all asking me when they can buy the cream.” – Former NBA player (retired 2016)
  • “My achilles flares up, especially when I train and your CBD product helps me recover faster so I can keep training.” – Ironman triathlete and training coach for over 125 current and former NBA players
  • “I’ve had chronic neck pain for over 20 years and I’ve tried everything. My doctor wants me to try steroid injections into my neck next. But after your trying your lotion, I’m going to need a steady supply because it’s the only thing that has ever worked. Seriously, when can I get some more.” – In home trial participant, 38-year old woman, reporter 
  • “After a half day of work, I have debilitating wrist and elbow pain. I’ve had it since a car accident and physical therapy didn’t help. I don’t like taking painkillers. After using your lotion, I felt immediate relief and it lasted for hours. I’ve been using it for a few days and now I don’t have to interrupt my schedule because of pain.” - In home trial participant, 44-year old woman, lawyer 
  • “I often have trouble concentrating because of the pain in my back. After applying your cream, even an hour later, I didn't even notice the pain in my back. I felt like I could focus again on my normal tasks. The cream smells really nice and a little goes a long way. I know that for me, this was something that helps me get through the hard part of my day because of my back. It helps me power through the day.” – In home trial participant, 29 year old woman, Pilates teacher 


The shortest duration of relief was 90 minutes. Some people had their pain go away completely after continued use. Every single trial user felt some type of pain relief.


How it works: 

  • The top layer of the skin, called the stratum corneum, is designed to protect the body by keeping harmful substances out. 

  • The topicals designed by RMR Laboratories work by creating an intercellular pathway directly through the skin. The pharmaceutical technology has been shown to deliver active ingredients up to 25 millimeters below the skin in a non-toxic, non-traumatic way.



Market:

2016 was a watershed year for the cannabis industry.

Cannabis products are now legal medically in 29 states and more than 60% of the population believes it should be legal everywhere.

The industry is being driven by the health and wellness sector which will be worth $25B by 2022 with tens of millions of consumers entering the market. 

Number of people in the United States affected by:

  • Chronic Pain: 110M
  • Migraines: 76M
  • Insomnia: 60M
  • Anxiety: 40M
  • Arthritis: 40M
  • Depression: 16M

Product Development:

We are ready to begin production on our products to address sports injuries and chronic pain.


Future roadmap:

We are poised to meet the needs of the tens of millions of people who will be turning to cannabis to treat their health ailments.

Our skin-penetrating technology provides a platform to quickly and efficiently address new health applications as well as build depth within current product lines.

We have only begun to scratch the surface on the therapeutic effects of different delivery systems and cannabis strains. In addition to topicals, we have future plans to expand into additional health and wellness product categories. 



Competition:

RMR Laboratories has a unique position in the marketplace. 

There are no topicals that contain our proprietary transdermal chemistry to deliver the pain-relieving properties of cannabis through the skin.

Our topicals address the source of the muscle or joint inflammation rather than try to mask the pain like existing pain relief creams do. NSAIDS can cause unwanted side effects like stomach irritation. Finally, unlike opioids, our pain relieving topicals have a localized effect, are not psychoactive (in the case of CBD), and are convenient to use because they do not impair motor function. 



What's next:

Our plans are to launch our topical products to address chronic pain and sports injuries in 1Q2018.

Our first three markets for product launch will be in Colorado, Oregon, and California. We are currently finalizing pre-orders from these three markets for $2.2M in revenue in the first half of 2018.

Our exclusive partnership with Advanced Nutrients for production and distribution expands our reach into every major market for medical and recreational cannabis, both in the US and internationally. 

Our operating model allows us to scale quickly and efficiently. We centralize our research and production in California and ship the formula base without cannabis actives to each market where the end products are produced.  




Use of proceeds: 

The proceeds from the campaign will be used on three priorities: 

  1. Production: Build up raw material inventory to begin production of our products ready to commercialize. 
  2. R&D: Scale research and development, including headcount, to address additional health and wellness applications identified in our product roadmap. 
  3. Marketing: Finalize product branding. Increase market research and user testing to determine product effectiveness and positioning. 

Meet the CEO

Mike Lui

I believe in the power of high expectations on the performance of people and teams. I believe that everyone has a ceiling that they cannot see, but if they continue to strive and persevere, that high ceiling may come into view. That's why I believe in the power of the work we are doing at RMR Laboratories. If we can develop products to reduce people's pain in a meaningful way without paralyzing addictions or side effects, then we've given them a chance to set and strive for those high expectations.

Thank you for taking some time to learn about the work we are doing at RMR. I'm proud of the progress the team has made in such a short period of time. Our first flagship CBD formulation has garnered tremendous response from our trial participants and I can't wait to make it available to all those that experience chronic pain. 

But we're just getting started, and I'm just as excited about the rest of our roadmap. We finally have the ability to use clinically valid transdermal technology to steer the healing properties of cannabis to where we need it. That to me is game-changing. 

I hope you'll join us. 

- Mike

Deal terms


Valuation cap

$16,000,000

The maximum valuation at which your investment converts into equity shares or cash.
Learn more

Discount

0%

If a trigger event for RMR Laboratories occurs, the discount provision gives investors equity shares (or equal value in cash) at a reduced price.
Learn more.

Minimum investment

$100

The smallest investment amount that RMR Laboratories is accepting.
Learn more

Funding goal

$1.07M

RMR Laboratories must achieve its minimum goal of $50K before the deadline. The maximum amount the offering can raise is $1.07M.
Learn more

Deadline
RMR Laboratories needs to reach their minimum funding goal before the deadline ( ). If they don’t, all investments will be refunded.
Learn more
Type of security

Crowd SAFE

A SAFE allows an investor to make a cash investment in a company, with rights to receive certain company stock at a later date, in connection with a specific event. · Learn more

How it works

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by RMR Laboratories, Inc. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
RMR Laboratories Crowd SAFE RmR Laboratories (renamed as G&G) - Certification of Dissolution .pdf RMR Final Form C.pdf

Bonus perks

In addition to your Crowd SAFE, you'll receive perks for investing in RMR Laboratories.
Invest
$1,000
Receive
  • One year's supply of our chronic pain CBD cream. (12 x 25 ml product) *subject to availability in your home state
Invest
$2,500
Receive
  • Three year's supply of our chronic pain CBD cream. (12 x 25ml product). Plus, one year supply of another product of your choosing ( 12 x 25ml) from our catalog. *subject to availability in your home state
Invest
$5,000
Receive
  • All the above, plus an autographed item from one of our endorsers.
Invest
$10,000
Receive
  • All the above, plus an exclusive invite to a BigMike launch party. *travel not included
Invest
$25,000
Receive
  • All of the above, plus exclusive invite to the annual investor retreat, including travel.

Why others invested

See all reviews (0) See all (0)

I am retired from the pharmaceutical business and want to support this vision.

Profile picture of Jeff Jones
Jeff Jones
Investor
over 7 years ago

1. Fast growing market as a result of favorable regulatory environment. 2. Strong technology differentiates its product from competitors. 3. Implied forward revenue multiples are in line with those of comparable companies and transactions.

Profile picture of Yating Xia
Yating Xia
Active investor
over 7 years ago

I invested bc I truly believe the use of marijuana in a non-toxic way may be beneficial to improve body pain. RMR, I believe, has what it takes to achieve this goal and succeed in such innovative industry. Thank you for letting me be part of it.

Profile picture of Cornelia Schepis
Cornelia Schepis
Active investor
about 7 years ago

About RMR Laboratories

Legal Name
RMR Laboratories, Inc
Founded
Aug 2017
Form
Delaware Corporation
Employees
2
Website
rmrlab.com
Social Media
Headquarters
Google Map location of of RMR Laboratories
Via Dolce , Marina del Rey, CA
Headquarters
Via Dolce, Marina del Rey, CA, United States 90292

RMR Laboratories Team
Everyone helping build RMR Laboratories, not limited to employees

Profile picture of Michael  Lui
Michael Lui
CEO
Featured in Superheroes · Read
6+ years in healthcare/life sciences experience :: Founder - OmicMD, genomic medicine platform :: Launched AmazonGo and AmazonBooks for Amazon :: Manager, Deloitte Consulting
Profile picture of Leila Fenelon
Leila Fenelon
Brand & Consumer Research
12+ years in marketing, new products and consumer insights :: Founder: Illume Insights :: Managed Herbal Essences business for P&G :: Launched 20+ products at Hyland’s, a homeopathic pharma company
Michael Lui
CEO
Leila Fenelon
Brand & Consumer Research

Press

These veterans may be the future of cannabis-based pharma...
We Are The Mighty
·
Nov 13, 2017

Blake speaks with Army veteran turned co-founder and CEO of RMR Laboratories, Mike Lui, about his over-the-counter cannab...

Logo of RMR Laboratories

RMR Laboratories

RMR Laboratories successfully raised $784,329 from 951 investors on January 1, 2018
Profile picture of William  Skyles
Profile picture of Amy Cima
Profile picture of Tom Knochel
Profile picture of Marcus Singleton
Profile picture of Jan Bommerez
William , Amy, Tom, Marcus, Jan, and 946 others invested. 320 Reviews
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Instruments
  • Crowd SAFE
  • Tokenized assets
Company
  • About
  • Journal
  • Events
  • Contact
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

All related securities activity is conducted by OpenDeal Broker LLC a registered broker-dealer, Member of FINRA and SiPC, an affiliate of OpenDeal Inc. and OpenDeal Portal LLC, located at 149 5th Avenue, 10th Floor, New York, NY 10010. Please check our background on FINRA’s BrokerCheck.

Certain pages discussing the mechanics and providing educational materials regarding regulation crowdfunding offerings may refer to OpenDeal Broker LLC and OpenDeal Portal LLC collectively as “Republic”, solely for explanatory purposes.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment recommendations and no communication, through this Site, or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Investment opportunities posted on this Site are private placements of securities that are not publicly traded, involve a high degree of risk, may lose value including the total loss of invested capital, are subject to holding period requirements and are intended for investors who do not need a liquid investment. Past performance is not indicative of future results. Investors must be able to afford the loss of their entire investment. Only qualified investors, who understand the risks of early-stage investment and who meet the Republic's investment criteria may invest. Investors may be restricted to only Accredited Investors or non-U.S. persons, to invest in offerings hosted by OpenDeal Broker. Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their officers, directors, agents and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this Site or the use of information on this site. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal and financial advisors.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Investors should verify any issuer information they consider important before making an investment.

Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. Therefore, when you use the Services we will ask for your name, address, date of birth, and other information that will allow us to identify you. We may also ask to see your driver's license, passport or other identifying documents.

Republic and its affiliates are not and do not operate or act as a bank. Certain banking services are provided by BankProv, member FDIC / member DIF. FDIC coverage only applies in the event of bank failure. Digital (crypto) assets and investment products are not insured by the FDIC, may lose value, and are not deposits or other obligations of BankProv and are not guaranteed by BankProv. Terms and conditions apply.

Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC